Purchase this article with an account.
M. Elman, A. Elman, A. Glasser, D. Braver; Endophthalmitis Following Anti-VEGF Injections in a Retinal Practice Setting. Invest. Ophthalmol. Vis. Sci. 2008;49(13):976. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Evaluate the incidence, presentation, and outcome of patients presenting with endophthalmitis post intravitreal injection of anti-VEGF drugs
Retrospective review of charts of patients undergoing intravitreal anti-VEGF injections between December 1, 2004 and November 30, 2007.
Between December 1, 2004 and November 30, 2007, 1,303 Macugen injections were administered; one eye developed endophthalmitis. Between July 1, 2006 and November 30, 2007, 3,057 Lucentis injections were given; five eyes developed endophthalmitis. All patients were seen post-injection within the first 7 days after injection. Of the six patients developing endophthalmitis,three were asymptomatic and were diagnosed as a result of the scheduled followup.
Early detection may of endophthalmitis may be facilitated by scheduled followup examination.
This PDF is available to Subscribers Only